Clinical Trial: Observational Study With Erosive Gastroesophageal Reflux Disease With JAQBO(R) ODT

U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07937059) titled 'Observational Study With Erosive Gastroesophageal Reflux Disease With JAQBO(R) ODT' on Nov. 08.

Brief Summary: The purpose of this study is to evaluate patient characteristics, effectiveness, safety, and satisfaction in patients treated with JAQBO(R) ODT. 20 mg(Zastaprazan citrate) for Erosive Gastroesophageal Reflux Disease in a real-world clinical setting.

Study Start Date: Feb. 26

Study Type: OBSERVATIONAL

Condition: Erosive Gastroesophageal Reflux Disease

Recruitment Status: COMPLETED

Sponsor: Jeil Pharmaceutical Co., Ltd.

Disclaimer: Curated by HT Syndication....